Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.

Using a three‐dimensional model of G protein‐coupled receptors (GPCR), we have previously succeeded in docking the neurohypophysial hormone arginine‐vasopressin (AVP) into the V1a receptor. According to this model, the hormone is completely embedded in the transmembrane part of the receptor. Only the side chain of the Arg residue at position 8 projects outside the transmembrane core of the receptor and possibly interacts with a Tyr residue located in the first extracellular loop at position 115. Residue 8 varies in the two natural neurohypophysial hormones, AVP and oxytocin (OT); similarly, different residues are present at position 115 in the different members of the AVP/OT receptor family. Here we show that Arg8 is crucial for high affinity binding of AVP to the rat V1a receptor. Moreover, when Tyr115 is replaced by an Asp and a Phe, the amino acids naturally occurring in the V2 and in the OT receptor subtypes, the agonist selectivity of the V1a receptor switches accordingly. Our results indicate that the interaction between peptide residue 8 and the receptor residue at position 115 is not only crucial for agonist high affinity binding but also for receptor selectivity.

[1]  D. Bichet,et al.  Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. , 1988, The New England journal of medicine.

[2]  J. Novotný,et al.  Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity. , 1994, The Journal of biological chemistry.

[3]  K. Mori,et al.  Structure and expression of a human oxytocin receptor , 1992, Nature.

[4]  T. Sugimoto,et al.  Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. , 1994, The Journal of biological chemistry.

[5]  J. D. Elliott,et al.  Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Acher.  Neurohypophysial peptide systems: processing machinery, hydroosmotic regulation, adaptation and evolution , 1993, Regulatory Peptides.

[7]  Gebhard F. X. Schertler,et al.  Projection structure of rhodopsin , 1993, Nature.

[8]  V. Hruby,et al.  Conformational and structural considerations in oxytocin-receptor binding and biological activity. , 1990, Annual review of pharmacology and toxicology.

[9]  M. Thibonnier,et al.  Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. , 1994, The Journal of biological chemistry.

[10]  B. Cantau,et al.  (3H)-vasopressin binding to isolated rat hepatocytes and liver membranes: regulation by GTP and relation to glycogen phosphorylase activation. , 1980, Journal of receptor research.

[11]  J Hoflack,et al.  Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. , 1992, Journal of medicinal chemistry.

[12]  E. Kojro,et al.  Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor. , 1993, Biochemistry.

[13]  P. Mannucci,et al.  1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASE , 1977, The Lancet.

[14]  G. Guillon,et al.  Stimulation, by vasopressin and other agonists, of inositol-lipid breakdown and inositol phosphate accumulation in WRK 1 cells. , 1986, The Biochemical journal.

[15]  C. Strader,et al.  Structure and function of G protein-coupled receptors. , 1994, Annual review of biochemistry.

[16]  C. Turck,et al.  Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface , 1994, Nature.

[17]  J Hoflack,et al.  Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. , 1991, Molecular pharmacology.

[18]  C. Fraser,et al.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. , 1992, The Biochemical journal.

[19]  Michael J. Brownstein,et al.  Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus , 1992, Nature.

[20]  G A Petsko,et al.  Amino‐aromatic interactions in proteins , 1986, FEBS letters.

[21]  M. Manning,et al.  Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin. , 1993, Journal of receptor research.

[22]  T. Schwartz,et al.  Locating ligand-binding sites in 7TM receptors by protein engineering. , 1994, Current opinion in biotechnology.

[23]  E. Tribollet,et al.  125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand. , 1988, European journal of pharmacology.

[24]  M. Caron,et al.  Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function. , 1992, Annual review of pharmacology and toxicology.

[25]  F. Fahrenholz,et al.  Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line. , 1993, European journal of biochemistry.

[26]  T. Barth,et al.  Vasopressin-sensitive kidney adenylate cyclase. Structural requirements for attachment to the receptor and enzyme activation: studies with vasopressin analogues. , 1975, The Journal of biological chemistry.

[27]  C. Barberis,et al.  Molecular cloning of the receptor for human antidiuretic hormone , 1992, Nature.

[28]  M. Manning,et al.  Novel approach to the design of synthetic radioiodinated linear V1A receptor antagonists of vasopressin. , 2009, International journal of peptide and protein research.

[29]  J. Heierhorst,et al.  Structure, function, and phylogeny of [Arg8]vasotocin receptors from teleost fish and toad. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Strosberg.  Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins. , 1991 .

[31]  M. Brownstein,et al.  Molecular cloning and expression of a rat Via arginine vasopressin receptor , 1992, Nature.